RxDoctor Payments Data

Jacquelyn Esterling

Family · Duluth, GANPI 1316557697

Payments from drug & device makers

$1,780in general payments, 2019–2025

Across 70 payments — averaging $25.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$273
  • AstraZeneca$219
  • Amgen$213
  • Otsuka America Pharmaceutical, Inc.$188
  • Exact Sciences$101
  • Corium, LLC$101
  • plus $685 from 19 others

What the payments were for

  • Food & beverage$1,780100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,780 in reported general payments places this provider in the 75th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin33$33,739
MounjaroTirzepatide20$29,225
OzempicSemaglutide20$18,040
Lidocaine12$2,633
Fluticasone-SalmeterolFluticasone Propion/Salmeterol24$2,012
SynthroidLevothyroxine Sodium18$1,320
Levothyroxine Sodium127$970
Albuterol Sulfate HfaAlbuterol Sulfate52$919
Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide18$859
Fenofibrate16$796
Atorvastatin Calcium141$794
Metformin Hcl ErMetformin Hcl64$722
Rosuvastatin Calcium64$683
Losartan Potassium92$657
Gabapentin39$626

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Olanzapine$62$29,50940 claims
Novo NordiskOzempic$52$18,04020 claims
AbbVieSynthroid$273$1,32018 claims
Almatica Pharma LLCSertraline Hcl$19$44562 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 6,258 family providers in Georgia.

Other family in Duluth

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →